The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

 

Medtronic Inc

NYSE: MDT
Last

(U.S.) $73.48

Today's change+0.69 +0.95%
Updated November 26 4:00 PM EST. Delayed by at least 15 minutes.
 

Medtronic Inc

NYSE: MDT
Last

(U.S.) $73.48

Today's change+0.69 +0.95%
Updated November 26 4:00 PM EST. Delayed by at least 15 minutes.

Medtronic Inc Hits New 52-week High

Medtronic Inc closed up Wednesday by (U.S.)$0.69 or 0.95% to (U.S.)$73.48 and setting a new 52-week high. Over the last five days, shares have gained 2.40% and 28.04% year to date. Shares have outperformed the S&P 500 by 13.41% during the last year.

Key company metrics

  • Open(U.S.) $72.82
  • Previous close(U.S.) $72.79
  • High(U.S.) $73.55
  • Low(U.S.) $72.76
  • Bid / Ask-- / --
  • YTD % change+28.04%
  • Volume5,062,731
  • Average volume (10-day)7,234,193
  • Average volume (1-month)6,846,144
  • Average volume (3-month)8,940,992
  • 52-week range(U.S.) $53.33 to (U.S.) $73.55
  • Beta1.05
  • Trailing P/E24.80×
  • P/E 1 year forward18.16×
  • Forward PEG2.85×
  • Indicated annual dividend(U.S.) $1.22
  • Dividend yield1.66%
  • Trailing EPS(U.S.) $2.96
Updated November 26 4:00 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+17.35%

Based on its net profit margin of 17.35%, Medtronic Inc is less effective than other companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.23%Sector:HealthcareIndustry:Medical Equipment, Supplies & Distribution
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2015Q4/2014Q3/2014Q2/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJul 25, 201407/25/2014Apr 25, 201404/25/2014Jan 24, 201401/24/2014Oct 25, 201310/25/2013
Revenue4,2734,5654,1634,194
Total other revenue--------
Total revenue4,2734,5654,1634,194
Gross profit3,1683,3943,1133,104
Total cost of revenue1,1051,1711,0501,090
Total operating expense3,1854,0743,1833,045
Selling / general / administrative1,5061,5391,4541,438
Research & development365385360372
Depreciation / amortization87868988
Interest expense (income), net operating--------
Unusual expense (income)7183418524
Other operating expenses, total51594533
Operating income1,0884919801,149
Interest income (expense), net non-operating-97-----95
Gain (loss) on sale of assets--------
Other--------
Income before tax1,0834819551,116
Income after tax871448762902
Income tax, total21233193214
Net income871448762902
Total adjustments to net income--------
Net income before extra. items871448762902
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items871448762902
Inc. avail. to common incl. extra. items871448762902
Diluted net income871448762902
Dilution adjustment----0--
Diluted weighted average shares1,0051,0121,0101,009
Diluted EPS excluding extraordinary itemsvalue per share0.870.440.750.89
Dividends per sharevalue per share0.310.280.280.28
Diluted normalized EPSvalue per share0.921.210.900.91